Compare Aecom (ACM) vs BioNTech SE - ADR (BNTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aecom vs BioNTech SE - ADR — how do they compare? Aecom trades at $67.11 (market cap $8.62B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: BioNTech SE - ADR is far larger — about 2.7× Aecom's market cap, and Aecom pays a 1.77% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| ACM | BNTX | |
|---|---|---|
Market Cap | $8.62B | $23.31B |
Sector | Industrials | Health |
52-Week High | $134.35 | $119.34 |
52-Week Low | $66.86 | $83.89 |
Enterprise Value | $10.81B | $6.60B |
Dividend Yield | 1.77% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Aecom
Aecom is one of the largest global providers of design, engineering, construction, and management services. The firm serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $13.3 billion in sales and $701 million in adjusted operating income in fiscal 2021.
Read more on ACM →About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →
